We are live on
!
Find out more
Larimar Therapeutics
LRMR
LRMR
49 hedge funds and large institutions have $27.7M invested in Larimar Therapeutics in 2019 Q4 according to their latest regulatory filings, with 13 funds opening new positions, 7 increasing their positions, 15 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
63% more capital invested
Capital invested by funds: $17M → $27.7M (+$10.7M)
0.44% more ownership
Funds ownership: 5.12% → 5.57% (+0.44%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
4% less funds holding
Funds holding: 51 → 49 (-2)
13% less first-time investments, than exits
New positions opened: 13 | Existing positions closed: 15
53% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 15
Holders
49
Holders Change
-2
Holders Change %
-3.92%
% of All Funds
0.97%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
13
Increased
7
Reduced
15
Closed
15
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
SCM
Sio Capital Management
New York
|
+$1.82M |
| 2 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$796K |
| 3 |
O
OrbiMed
New York
|
+$654K |
| 4 |
6CM
683 Capital Management
New York
|
+$295K |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$277K |
Top Sellers
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
-$1.44M |
| 2 |
Dimensional Fund Advisors
Austin,
Texas
|
-$490K |
| 3 |
BlackRock
New York
|
-$290K |
| 4 |
Goldman Sachs
New York
|
-$205K |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$197K |
